Calcium Hopantenate Hemihydrate powder manufacturer CAS No.: 17097-76-6 98.0% purity min. for supplement ingredients
Product Video
Product Parameters
|
Product name |
Calcium Hopantenate Hemihydrate |
|
Other name |
calcium (R)-4-(2,4-dihydroxy-3,3-dimethylbutanamido)butanoate hydrate
calcium hopantenate Calcium hopantenate hemihydrate Hopantenate (calcium) calciumhopantenate |
|
CAS No. |
17097-76-6 |
|
Molecular formula |
C20H38CaN2O11 |
|
Molecular weight |
522.6 |
|
Purity |
98.0% |
|
Appearance |
powder |
|
Application |
Dietary Supplement Raw Material |
Product introduction
Calcium Hopantenate Hemihydrate, also known as calcium (R)-4-(2,4-dihydroxy-3,3-dimethylbutanamido)butanoate hydrate, is derived from triphenic acid, Pantenic acid is a derivative of pantethine, a component of coenzyme A. Calcium Hopantenate Hemihydrate is thought to enhance brain function by increasing brain metabolism and blood flow and improving the synthesis and release of acetylcholine, Its applications include age-related memory loss.
Feature
(1) High purity: Through precision manufacturing processes, high-purity Calcium Hopantenate Hemihydrate can be obtained. High purity means better bioavailability and fewer adverse reactions.
(2) Safety: Calcium Hopantenate Hemihydrate is a compound that has been proven safe for human use.
(3) Stability: Calcium Hopantenate Hemihydrate show good stability and can maintain their activity and effectiveness under different environments and storage conditions.
Applications
At present, Calcium Hopantenate Hemihydrate has gained important applications in cognitive disorders and memory disorders. It is widely used in clinical practice for its potential to enhance brain metabolism, improve blood flow, and modulate neurotransmitter systems involved in memory and learning processes. Calcium Hopantenate Hemihydrate has been shown to be effective in improving age-related memory loss . Calcium Hopantenate Hemihydrate also has broad application prospects. Furthermore, the compound's safety profile and favorable pharmacokinetic properties make it an attractive candidate for combination therapy. In conclusion, Calcium Hopantenate Hemihydrate currently occupies an important role in cognitive impairment, and its potential application in other neurodegenerative diseases shows great promise for future advances.
